Brokerages Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) PT at $11.06

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has earned an average rating of “Hold” from the eleven research firms that are currently covering the company, MarketBeat reports. Six research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $11.0625.

Several equities analysts have recently weighed in on the stock. Barclays lifted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock an “overweight” rating in a research note on Friday, January 16th. Raymond James Financial reaffirmed an “outperform” rating and issued a $13.00 price objective on shares of Aveanna Healthcare in a report on Friday, December 5th. Royal Bank Of Canada lifted their price objective on shares of Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a research note on Thursday, January 15th. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 3rd. Finally, UBS Group raised their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a report on Thursday, January 15th.

Insider Buying and Selling at Aveanna Healthcare

In other news, insider Edwin C. Reisz sold 60,769 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $438,144.49. Following the sale, the insider directly owned 1,447,057 shares in the company, valued at $10,433,280.97. This represents a 4.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Matthew Buckhalter sold 13,512 shares of the stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $97,421.52. Following the completion of the sale, the chief financial officer directly owned 529,243 shares in the company, valued at approximately $3,815,842.03. The trade was a 2.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 998,595 shares of company stock worth $7,567,770 in the last three months. 7.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Aveanna Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of AVAH. Vanguard Group Inc. lifted its stake in Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after purchasing an additional 1,535,351 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Aveanna Healthcare by 17.7% during the 4th quarter. Geode Capital Management LLC now owns 1,849,057 shares of the company’s stock valued at $15,110,000 after purchasing an additional 278,429 shares in the last quarter. AustralianSuper Pty Ltd bought a new position in shares of Aveanna Healthcare in the third quarter worth $15,743,000. Nuveen LLC raised its position in shares of Aveanna Healthcare by 135.9% in the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after buying an additional 905,316 shares in the last quarter. Finally, State Street Corp raised its position in shares of Aveanna Healthcare by 20.9% in the fourth quarter. State Street Corp now owns 1,483,265 shares of the company’s stock worth $12,118,000 after buying an additional 256,392 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Trading Down 0.6%

Shares of Aveanna Healthcare stock opened at $6.96 on Monday. The stock has a market capitalization of $1.45 billion, a P/E ratio of 19.33 and a beta of 2.07. Aveanna Healthcare has a 52-week low of $3.73 and a 52-week high of $10.32. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. The stock’s 50-day simple moving average is $8.03 and its 200 day simple moving average is $8.54.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.